{
    "clinical_study": {
        "@rank": "46728", 
        "acronym": "ADVANCE DA", 
        "brief_summary": {
            "textblock": "This study is intended to collect data regarding the clinical utility, safety and\n      performance of the Medtronic CoreValve\u00ae System for Transcatheter Aortic Valve Implantation\n      (TAVI) in patients with severe symptomatic aortic valve stenosis for which treatment via\n      direct aortic access (DA) is selected. As part of the study analysis, resource utilization\n      together with the Quality of Life questionnaires data will provide an important input into\n      cost effectiveness analysis."
        }, 
        "brief_title": "ADVANCE Direct Aortic", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Aortic Stenosis", 
            "Valvular Heart Disease", 
            "Transcatheter Aortic Valve Implantation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Aortic Valve Stenosis", 
                "Heart Diseases", 
                "Heart Valve Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Severe symptomatic aortic valve stenosis requiring treatment\n\n          2. Acceptable candidate for elective treatment with the Medtronic CoreValve\u00ae  System\n             according to the most recent version of the Medtronic CoreValve\u00ae  Instructions For\n             Use\n\n          3. 21 years of age or older\n\n          4. Patient is willing and able to comply with all protocol-specified follow-up\n             evaluations\n\n          5. The patient or legal representative has been informed of the nature of the study and\n             has consented to participate, and has authorized the collection and release of\n             his/her medical information by signing a consent form (\"Patient Informed Consent\n             Form\")\n\n          6. Patient will receive the CoreValve\u00ae device via direct aortic approach TAVI -\n\n        Exclusion Criteria:\n\n          1. Known hypersensitivity or contraindication to aspirin, heparin, ticlopidine,\n             clopidogrel, nitinol, or sensitivity to contrast media which cannot be adequately\n             pre-medicated\n\n          2. Sepsis, including active endocarditis\n\n          3. Recent myocardial infarction (<30 days)\n\n          4. Left ventricular or atrial thrombus by echocardiography\n\n          5. Uncontrolled atrial fibrillation\n\n          6. Mitral or tricuspid valvular insufficiency (>grade II)\n\n          7. Previous aortic valve replacement (mechanical valve or stented bioprosthetic valve)\n\n          8. Evolutive or recent (within 6 months of implant procedure) cerebrovascular accident\n             (CVA) or transient ischemic attack (TIA)\n\n          9. Patients with:\n\n               1. Vascular conditions that make insertion and endovascular access to the aortic\n                  valve impossible, or\n\n               2. Symptomatic carotid or vertebral arterial narrowing (>70%) disease, or\n\n               3. Thoracic aortic aneurysm in the path of delivery system\n\n         10. Bleeding diathesis or coagulopathy\n\n         11. Patient refuses blood transfusion\n\n         12. Estimated life expectancy of less than 12 months unless TAVI is performed\n\n         13. Creatine clearance <20 mL/min\n\n         14. Active gastritis or peptic ulcer disease\n\n         15. Pregnancy or intent to become pregnant during study follow up\n\n         16. Patient is participating in another trial that may influence the results of this\n             study\n\n             -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with severe aortic stenosis who are scheduled for an elective transcatheter\n        aortic valve implantation and who are selected (e.g. because of an calcified femoral\n        artery) to receive the CoreValve\u00ae device via direct aortic access."
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01676727", 
            "org_study_id": "V1 04JUN2012"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Transcatheter Aortic valve Implantation", 
            "Heart Valve Diseases", 
            "Cardiovascular Diseases"
        ], 
        "lastchanged_date": "August 29, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Trinec", 
                        "country": "Czech Republic", 
                        "zip": "739 61"
                    }, 
                    "name": "Nemocnice Podlesi Trinec"
                }, 
                "investigator": [
                    {
                        "last_name": "Marian Branny, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Piotr Branny, M.D.", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Massy", 
                        "country": "France", 
                        "zip": "91300"
                    }, 
                    "name": "H\u00f4pital priv\u00e9 Jacques Cartier"
                }, 
                "investigator": [
                    {
                        "last_name": "Bernard Chevalier, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Romano Mauro, M.D.", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France", 
                        "zip": "35033 Cedex 9"
                    }, 
                    "name": "CHU Rennes"
                }, 
                "investigator": [
                    {
                        "last_name": "Jean Philippe Verhoye, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Herve Le Breton, M.D.", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31059 CEDEX 9"
                    }, 
                    "name": "Hopital de Rangueil"
                }, 
                "investigator": [
                    {
                        "last_name": "Bertrand Marcheix, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Nicolas Dumonteil, M.D.", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Halle (Saale)", 
                        "country": "Germany", 
                        "zip": "06120"
                    }, 
                    "name": "Universit\u00e4tsklinikum Halle (Saale)"
                }, 
                "investigator": {
                    "last_name": "Hasan Bushnaq, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Trier", 
                        "country": "Germany", 
                        "zip": "54292"
                    }, 
                    "name": "Krankenhaus der Barmherzigen Bruder"
                }, 
                "investigator": [
                    {
                        "last_name": "Karl Friedrich, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Karl Eugen Hauptmann, M.D.", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brescia", 
                        "country": "Italy", 
                        "zip": "25123"
                    }, 
                    "name": "Azienda spedaliera Spedali Civili Di Brescia"
                }, 
                "investigator": [
                    {
                        "last_name": "Frederica Ettori, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Giuseppe Coletti, M.D.", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "zip": "20162"
                    }, 
                    "name": "Azienda spedaliera Niguarda Ca' Granda Milano"
                }, 
                "investigator": [
                    {
                        "last_name": "Giuseppe Bruschi, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Silvio Klugmann, M.D.", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eindhoven", 
                        "country": "Netherlands", 
                        "zip": "5623 EJ"
                    }, 
                    "name": "Catharina Ziekenhuis"
                }, 
                "investigator": [
                    {
                        "last_name": "Erwin Tan, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Guus Brueren, M.D.", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oslo", 
                        "country": "Norway", 
                        "zip": "0372"
                    }, 
                    "name": "Rikshospitalet HF"
                }, 
                "investigator": [
                    {
                        "last_name": "Gry Dahle, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Bjorn Bendz, M.D.", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zabrze", 
                        "country": "Poland", 
                        "zip": "41-800"
                    }, 
                    "name": "\u015al\u0105skie Centrum Chorob Serca"
                }, 
                "investigator": {
                    "last_name": "Marian Zembala, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SW3 6NP"
                    }, 
                    "name": "Royal Brompton & Harefield NHS Trust"
                }, 
                "investigator": [
                    {
                        "last_name": "Neil Moat, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Simon William Davies, M.D.", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Czech Republic", 
                "France", 
                "Germany", 
                "Italy", 
                "Netherlands", 
                "Norway", 
                "Poland", 
                "United Kingdom"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "CoreValve\u00ae ADVANCE Direct Aortic Study", 
        "overall_contact": {
            "email": "gwenn.wetzels@medtronic.com", 
            "last_name": "Gwenn Wetzels, PhD", 
            "phone": "+31 (0) 43 3566527"
        }, 
        "overall_contact_backup": {
            "email": "maarten.hollander@medtronic.com", 
            "last_name": "Maarten Hollander, MSc", 
            "phone": "+31 (0) 43 3566864"
        }, 
        "overall_official": [
            {
                "affiliation": "The Royal Brompton Hospital", 
                "last_name": "Neil Moat, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Azienda spedaliera Niguarda Ca' Granda Milano", 
                "last_name": "Giuseppe Bruschi, M.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Czech Republic: Ethics Committee", 
                "France: Institutional Ethical Committee", 
                "Germany: Ethics Commission", 
                "Netherlands: Medical Ethics Review Committee (METC)", 
                "Norway: Regional Ethics Commitee", 
                "Poland: Ethics Committee", 
                "United Kingdom: Research Ethics Committee", 
                "Italy: Ethics Committee"
            ]
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "All-cause mortality", 
            "safety_issue": "Yes", 
            "time_frame": "30 days post-implant"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01676727"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The combined safety endpoint is defined as a composite of:\nAll-cause mortality\nAll stroke\nLife-threatening bleeding\nAcute kidney injury\u2014Stage 3 (including renal replacement therapy)\nCoronary artery obstruction requiring intervention\nMajor vascular complication\nValve-related dysfunction requiring repeat procedure (BAV, TAVR, or SAVR)\nHigh degree AV block requiring permanent pacemaker implantation", 
            "measure": "Incidence of Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)-Combined safety endpoint", 
            "safety_issue": "Yes", 
            "time_frame": "1, 6 and 12 months"
        }, 
        "source": "Medtronic Bakken Research Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic Bakken Research Center", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2012"
    }
}